Principal Financial Group Inc. Lowers Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)

Principal Financial Group Inc. decreased its holdings in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 42.1% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 791,166 shares of the company's stock after selling 574,603 shares during the quarter. Principal Financial Group Inc. owned about 0.36% of Hims & Hers Health worth $23,379,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HIMS. Blume Capital Management Inc. increased its holdings in shares of Hims & Hers Health by 100.0% during the fourth quarter. Blume Capital Management Inc. now owns 1,200 shares of the company's stock valued at $29,000 after acquiring an additional 600 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Hims & Hers Health by 247.5% during the 1st quarter. UMB Bank n.a. now owns 1,310 shares of the company's stock valued at $39,000 after buying an additional 933 shares in the last quarter. Smartleaf Asset Management LLC lifted its position in shares of Hims & Hers Health by 4,415.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the company's stock valued at $36,000 after buying an additional 1,413 shares in the last quarter. Tsfg LLC bought a new stake in Hims & Hers Health during the 1st quarter valued at approximately $46,000. Finally, Fifth Third Bancorp raised its stake in Hims & Hers Health by 165.4% during the 1st quarter. Fifth Third Bancorp now owns 1,542 shares of the company's stock valued at $46,000 after purchasing an additional 961 shares during the period. Hedge funds and other institutional investors own 63.52% of the company's stock.

Insiders Place Their Bets

In other Hims & Hers Health news, insider Michael Chi sold 17,102 shares of the company's stock in a transaction on Tuesday, June 17th. The stock was sold at an average price of $59.75, for a total value of $1,021,844.50. Following the completion of the sale, the insider directly owned 278,654 shares in the company, valued at approximately $16,649,576.50. This represents a 5.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Oluyemi Okupe sold 23,107 shares of the company's stock in a transaction on Monday, June 23rd. The stock was sold at an average price of $47.25, for a total value of $1,091,805.75. Following the completion of the sale, the chief financial officer owned 63,222 shares of the company's stock, valued at $2,987,239.50. This represents a 26.77% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 670,250 shares of company stock worth $34,487,591. Insiders own 13.71% of the company's stock.

Analysts Set New Price Targets

A number of analysts have issued reports on HIMS shares. Needham & Company LLC reaffirmed a "hold" rating on shares of Hims & Hers Health in a research note on Monday, June 23rd. UBS Group set a $30.00 price objective on Hims & Hers Health in a research note on Monday, June 23rd. Wall Street Zen downgraded Hims & Hers Health from a "buy" rating to a "hold" rating in a research note on Saturday. Bank of America lifted their price objective on Hims & Hers Health from $22.00 to $26.00 and gave the stock an "underperform" rating in a research note on Tuesday, April 29th. Finally, Truist Financial set a $45.00 target price on Hims & Hers Health in a research report on Tuesday, June 24th. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $39.58.

Hims & Hers Health Stock Performance

Hims & Hers Health stock traded down $2.36 during mid-day trading on Friday, hitting $47.91. The company's stock had a trading volume of 18,925,676 shares, compared to its average volume of 23,898,503. The company has a 50 day moving average of $53.68 and a 200-day moving average of $41.05. The stock has a market cap of $10.72 billion, a PE ratio of 69.44, a P/E/G ratio of 1.76 and a beta of 2.02. Hims & Hers Health, Inc. has a one year low of $13.47 and a one year high of $72.98.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.12 by $0.08. The company had revenue of $586.01 million for the quarter, compared to the consensus estimate of $535.21 million. Hims & Hers Health had a return on equity of 22.75% and a net margin of 9.24%. Hims & Hers Health's quarterly revenue was up 110.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.05 EPS. On average, equities research analysts forecast that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.